Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...
WASHINGTON & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx®, Inc. today announced the results of two multi-center, randomized clinical trials showing clinically meaningful improvements in lung ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Compared with baseline, FEV 1 increased 5 years after ...
Connecticut COPD patients now have access to a new life-changing treatment in Hartford. The first patient at Saint Francis Hospital to get the procedure since it newly became available says it has ...
The MarketWatch News Department was not involved in the creation of this content. WHITTIER, Calif., Nov. 19, 2025 /PRNewswire/ -- PIH Health Whittier Hospital is now offering the Zephyr(R) ...
COPD treatments aim to improve patients' quality of life, with options including medication, rehabilitation, and invasive procedures. Emphysema significantly impacts patients' daily activities due to ...
Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that on December 1, 2025 (the “Grant Date”), Pulmonx ...
WHITTIER, Calif., Nov. 19, 2025 /PRNewswire/ -- PIH Health Whittier Hospital is now offering the Zephyr® Endobronchial Valve procedure, a breakthrough minimally invasive treatment option for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback